143 related articles for article (PubMed ID: 9113049)
1. [Macrolides: indications in 1997].
Bouhour D; Peyramond D
Presse Med; 1997 Mar; 26 Suppl 2():22-6. PubMed ID: 9113049
[TBL] [Abstract][Full Text] [Related]
2. [Macrolides. New therapeutic prospects].
Bryskier A; Labro MT
Presse Med; 1994 Dec; 23(38):1762-6. PubMed ID: 7831266
[TBL] [Abstract][Full Text] [Related]
3. [Role of macrolides in the treatment of respiratory tract infections in children].
Floret D
Arch Pediatr; 1995 Dec; 2(12):1184-91. PubMed ID: 8548000
[TBL] [Abstract][Full Text] [Related]
4. Macrolide antibiotics in paediatric infectious diseases.
Guay DR
Drugs; 1996 Apr; 51(4):515-36. PubMed ID: 8706592
[TBL] [Abstract][Full Text] [Related]
5. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
Appelbaum PC
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
[TBL] [Abstract][Full Text] [Related]
6. Resistant respiratory pathogens and extended-spectrum antibiotics.
Pichichero ME
Am Fam Physician; 1995 Nov; 52(6):1739-46. PubMed ID: 7484684
[TBL] [Abstract][Full Text] [Related]
7. [New macrolides].
Lecomte F; Benhamou D
Rev Med Interne; 1998 Apr; 19(4):255-61. PubMed ID: 9775151
[TBL] [Abstract][Full Text] [Related]
8. Telithromycin: new preparation. A needless addition to the other macrolides.
Prescrire Int; 2003 Feb; 12(63):8-11. PubMed ID: 12602373
[TBL] [Abstract][Full Text] [Related]
9. [Lower tract infections as potential indication for therapy with macrolides].
Jahnz-Rózyk K; Targowski T
Pol Merkur Lekarski; 2008 Nov; 25(149):426-8. PubMed ID: 19177781
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics in asthma.
Beuther DA; Martin RJ
Curr Allergy Asthma Rep; 2004 Mar; 4(2):132-8. PubMed ID: 14769262
[TBL] [Abstract][Full Text] [Related]
11. [Current antibiotic treatment of ENT infections in the child].
Luckhaupt H
HNO; 1991 Nov; 39(11):419-23. PubMed ID: 1769864
[TBL] [Abstract][Full Text] [Related]
12. Activity of roxithromycin against respiratory pathogens.
Facinelli B; Varaldo PE
J Chemother; 1991 Jan; 3 Suppl 1():33-5. PubMed ID: 12041781
[TBL] [Abstract][Full Text] [Related]
13. [New therapeutic uses of the macrolides].
Mihălţan F
Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
[No Abstract] [Full Text] [Related]
14. [Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].
Niki Y; Aoki N; Suzuki K; Matsumoto T
Jpn J Antibiot; 2009 Jun; 62(3):179-93. PubMed ID: 19882979
[No Abstract] [Full Text] [Related]
15. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
Bébéar C; Pereyre S; Peuchant O
Future Microbiol; 2011 Apr; 6(4):423-31. PubMed ID: 21526943
[TBL] [Abstract][Full Text] [Related]
16. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.
Markham A; Faulds D
Drugs; 1994 Aug; 48(2):297-326. PubMed ID: 7527329
[TBL] [Abstract][Full Text] [Related]
17. New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy.
Kirst HA; Sides GD
Antimicrob Agents Chemother; 1989 Sep; 33(9):1419-22. PubMed ID: 2684005
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of macrolides in lower respiratory tract infections.
Dietrich ES; Voegele T; Frank U; Daschner FD
Ann Pharmacother; 1999 Oct; 33(10):1125-6. PubMed ID: 10534230
[No Abstract] [Full Text] [Related]
20. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
Lorenz J
Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
